Clinical Trial Update: Effectiveness of Once-daily Dose Regimen of 7-day and 14-day High Dose Rabeprazole-levofloxacin Based Quadruple Therapy for H. Pylori Eradication in Thai Patients With Non-ulcer Dyspepsia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating once-daily high-dose rabeprazole-levofloxacin-based quadruple therapy for eradicating Helicobacter pylori in Thai patients with non-ulc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia
• Helicobacter Pylori Infection

Drugs mentioned

• Levofloxacin (Levofloxacin)
• Rabeprazole (rabeprazole)

Snippet

Sponsor: Thammasat University | Conditions: Helicobacter Pylori Infection | Phase 1 | Status: UNKNOWN